To Teabury22 from the YAHOO Board:
In order to answer your question, one does not need to be a rocket scientist to do some simple math and figure out a value for SEPR (after all, this is what WallStreet is all about. Assumptions and projections). With certain assumptions in place, such as a very conservative EPS of $5.30 in year 2002 as has been reported by several Analysts and based on FDA approval of Levalbuterol and today's collaboration agreements that have been signed, a P/E ratio of 30 and a discount rate of 25% per year, would clearly give you a price of ~$51-$52, which would be about 19% higher than where the stock is trading at right now. On the otherhand, if these assumptions prove to be wrong or incorrect, then your guess is as good as mine !!!!
No, I have not sold any of my shares yet, but if it pleases you, I promise I will let you know when I decide to do it. I am just afraid that it might take the price of SEPR down considerably.
I believe there were (3) large-size blocks (2x25,000 & a 12,500) traded today on the buy-side, but nothing to brag about. The daily volume was right about average.
Finally, another stellar performance by SEPR today: up a whopping 1/4 pt. with the DOW, Nasdaq & the Russell all flying through the roof. Take a look at AMGN, BGEN, MEDI, IMNR, ENMD and many others in the bioteck group, and tell me if SEPR is not under-performing ???
Mazen |
